Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular Heterogeneity
Shiv K. Gupta, Emily J. Smith, Ann C. Mladek, et al.
Frontiers in Oncology (2019) Vol. 8
Open Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies
Semer Maksoud
Molecular Neurobiology (2022) Vol. 59, Iss. 9, pp. 5326-5365
Closed Access | Times Cited: 21
Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma
I‐Tsang Chiang, Yu‐Chang Liu, Huashan Liu, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 2, pp. 616-634
Open Access | Times Cited: 20
Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
Priya Bisht, Vikash Kumar, Ruchi Pandey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Bi-directional regulation of AIMP2 and its splice variant on PARP-1-dependent neuronal cell death; Therapeutic implication for Parkinson's disease
Min Hak Lee, Ki-Hwan Um, Seok Won Lee, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance
Silvia Valtorta, Daniela Salvatore, Paolo Rainone, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5631-5631
Open Access | Times Cited: 28
Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma
Minsoo Khang, Ju-Hyun Lee, Teresa Lee, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 720
Open Access | Times Cited: 10
SERPINH1 and CTSZ are Key Markers of Glioma Angiogenesis
Haotian Wei, Xinlong Li, Peng Feng, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 2
Closed Access
Design and synthesis of novel caffeic acid phenethyl ester (CAPE) derivatives and their biological activity studies in glioblastoma multiforme (GBM) cancer cell lines
Bilgesu Onur Sucu, Elif Beyza Koc, Özgecan Şavluğ İpek, et al.
Journal of Molecular Graphics and Modelling (2022) Vol. 113, pp. 108160-108160
Closed Access | Times Cited: 15
Targeting epigenetic mechanisms of resistance to chemotherapy in gliomas
Panagiotis Skouras, Mariam Markouli, Ioanna Papadatou, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104532-104532
Closed Access | Times Cited: 3
DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance
Juliana Ferreira de Sousa, Rodolfo Bortolozo Serafim, Laura Marise de Freitas, et al.
Genetics and Molecular Biology (2019) Vol. 43, Iss. 1 suppl 1
Open Access | Times Cited: 24
DNA Repair Mechanisms and Therapeutic Targets in Glioma
Kevin B. Elmore, Lauren Schaff
Current Oncology Reports (2021) Vol. 23, Iss. 8
Closed Access | Times Cited: 19
Current and promising treatment strategies in glioma
Paulina Śledzińska, Marek Bebyn, Jacek Furtak, et al.
Reviews in the Neurosciences (2022) Vol. 34, Iss. 5, pp. 483-516
Closed Access | Times Cited: 14
Design and Synthesis of a Trifunctional Molecular System “Programmed” to Block Epidermal Growth Factor Receptor Tyrosine Kinase, Induce High Levels of DNA Damage, and Inhibit the DNA Repair Enzyme (Poly(ADP-ribose) Polymerase) in Prostate Cancer Cells
Julie Schmitt, Shanlong Huang, Elliot Goodfellow, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5752-5762
Closed Access | Times Cited: 20
Olaparib Is a Mitochondrial Complex I Inhibitor That Kills Temozolomide-Resistant Human Glioblastoma Cells
Luca X. Zampieri, Martina Sboarina, Andrea Cacace, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11938-11938
Open Access | Times Cited: 17
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
Mary‐Ann E. Xavier, Fernando Rezende, Ricardo Titze‐de‐Almeida, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1188-1188
Open Access | Times Cited: 16
Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study
Priya Bisht, Surendra Rajit Prasad, Khushboo Choudhary, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Novel strategies to overcome chemoresistance in human glioblastoma
Qing Tang, Ting Ren, Peiying Bai, et al.
Biochemical Pharmacology (2024), pp. 116588-116588
Closed Access | Times Cited: 2
Targeting the CINful genome: Strategies to overcome tumor heterogeneity
Chelsea E. Cunningham, Mackenzie J. MacAuley, Garima Yadav, et al.
Progress in Biophysics and Molecular Biology (2019) Vol. 147, pp. 77-91
Open Access | Times Cited: 19
Genetic and epigenetic profiling of BRCA1/2 in ovarian tumors reveals additive diagnostic yield and evidence of a genomic BRCA1/2 DNA methylation signature
Erfan Aref‐Eshghi, Jacob McGee, Victor P. Pedro, et al.
Journal of Human Genetics (2020) Vol. 65, Iss. 10, pp. 865-873
Open Access | Times Cited: 16
Temozolomide Resistance: A Multifarious Review on Mechanisms Beyond O-6-Methylguanine-DNA Methyltransferase
Vanishree Rao, Gautam Kumar, R. J. A. Vibhavari, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 6, pp. 817-831
Closed Access | Times Cited: 9
RETRACTED: A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells
Joydeep Mukherjee, Ajay Pandita, Kamalakar Chatla, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 592
Closed Access | Times Cited: 11
Restoring chemo-sensitivity to temozolomide via targeted inhibition of poly (ADP-ribose) polymerase-1 by naringin in glioblastoma
Vanishree Rao, Sri Pragnya Cheruku, Suman Manandhar, et al.
Chemical Papers (2021) Vol. 75, Iss. 9, pp. 4861-4871
Open Access | Times Cited: 11
Dianhydrogalactitol Overcomes Multiple Temozolomide Resistance Mechanisms in Glioblastoma
Miguel Jiménez-Alcázar, Álvaro Curiel‐García, Paula Nogales, et al.
Molecular Cancer Therapeutics (2021) Vol. 20, Iss. 6, pp. 1029-1038
Open Access | Times Cited: 10
Oncometabolite 2-hydroxyglutarate suppresses basal protein levels of DNA polymerase beta that enhances alkylating agent and PARG inhibition induced cytotoxicity
Kate M. Saville, Rasha Q. Al‐Rahahleh, Aisha H. Siddiqui, et al.
DNA repair (2024) Vol. 140, pp. 103700-103700
Open Access | Times Cited: 1
Role of stress granules in modulating senescence and promoting cancer progression: Special emphasis on glioma
Debmita Chatterjee, Oishee Chakrabarti
International Journal of Cancer (2021) Vol. 150, Iss. 4, pp. 551-561
Open Access | Times Cited: 8

Scroll to top